✦ LIBER ✦

Preclinical characterization of a new liquid ?immune globulin intravenous (human), 10% triple virally reduced solution? (IGIV, 10%TVR)*1

✍ Scribed by TESCHNER, W

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of a new 10% liquid, triple

✍ KREIL, T 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 25 KB

Efficacy, safety and tolerability of a n

✍ Church, J.A.; Leibl, H.; Stein, M.R.; Melamed, I.R.; Rubinstein, A.; Schneider, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 26 KB

Pathogen safety profile of a new 10% liq

✍ Kreil, T.R.; Poelsler, G.; Bailey, A.C.; Teschner, W.; Schwarz, H.P. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 31 KB